A surrogate biomarker for decreased fracture risk

Improvements in bone mineral density (BMD) after 2 years of osteoporosis drug therapy could serve as a surrogate biomarker for decreased fracture risk.

Osteoporosis

The osteoporosis drugs include bisphosphonate, arzoxifene, bazedoxifene, lasofoxifene, raloxifene, odanacatib, denosumab, anabolic drugs, and hormone replacement therapy.

webhnd.com

Ostrovit-Vit-amp-Min-90-Tabs-100-Multi-Vitamins-amp-Minerals-Complex-D-B12-C-Mg Cal-Mag-Vit-D3-Nature-039-s-Plus-90-Tabs Calcium-Magnesium-amp-Vit-D-250-Caps-by-Nature-039-s-Way
US $8.67 US $14.06 US $16.78 US $33.04

Leave your comment

avatar

This site uses Akismet to reduce spam. Learn how your comment data is processed.

  Subscribe  
Notify of